US Patent 9233156 Induction of IL-12 using immunotherapy
Patent 9233156 was granted and assigned to Immunovative Therapies on January, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9233156 Induction of IL-12 using immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
